Synthesis and Docking Studies of a Novel Tetrahydroquinazoline Derivative as Promising Scaffold for Acetylcholine Esterase Inhibition | ||||
Egyptian Journal of Chemistry | ||||
Article 13, Volume 63, Issue 12, December 2020, Page 4797-4804 PDF (1.37 MB) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/ejchem.2020.27985.2588 | ||||
View on SCiNiTO | ||||
Authors | ||||
Rawan A. Alsuhaimat1; Qais Abualassal2; zead abudyah3; Sherif S. Ebada4; Amgad Albohy 5 | ||||
1Faculty of Pharmacy, Mu’tah University, Al-Karak, 61166, Amman, Jordan | ||||
2Department of Applied Pharmaceutical Sciences, Faculty of Pharmacy, Isra University, Amman, Jordan | ||||
3Faculty of pharmacy / AL-isra university Amman / Jordan | ||||
4Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mu’tah University, Al-Karak, Jordan. and Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo, Egypt | ||||
5Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE), Egypt | ||||
Abstract | ||||
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative disorder. While pathological hallmarks of this disorder are known, the exact cause of AD remains unclear. Quinazoline was found to be a promising scaffold for the design and development of Acetylcholinesterase (AChE) inhibitors. In this study we report the synthesis of 1'-methyl-3', 4'-dihydro1'H-spiro[cyclopentane-1, 2'-quinazoline] (4) in 73.3% yield. The structure of compound 4 was confirmed with GC-MS, 1H and 13C-NMR. Acetylcholine esterase inhibition was studied virtually with docking into AChE active site and suggests potential use of 4 as a promising scaffold for acetylcholine esterase inhibitor design which might be useful for Alzheimer’s disease. | ||||
Keywords | ||||
Acetylcholine esterase inhibitor; Alzheimer disease; Quinazoline derivatives; Spiro compounds; Molecular Docking | ||||
Statistics Article View: 654 PDF Download: 527 |
||||